Abbott India Ltd.

India is a high-quality MNC pharma company focused on branded formulations in gastro, metabolic, and women’s health therapies It enjoys strong pricing power, a premium brand image, and an asset-light, high-ROCE business model Revenue growth is driven by chronic portfolio expansion and high prescription stickiness in India. Key risks include regulatory price caps on essential drugs and dependence on parent for portfolio and strategy